Tagmokitug
Tagmokitug (CHS-114) is a fully human IgG1 antibody that targets CCR8. Tagmokitug has the potential for the study of head and neck squamous cell carcinoma (HNSCC) . The isotype control for Tagmokitug can refer to Human IgG1 lambda2, Isotype Control (HY-P990096) [1].
Product Specifications
CAS Number
[3024486-14-1]
Product Name Alternative
CHS-114; SRF-114
UNSPSC
12352203
Target
CCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Tagmokitug]
References & Citations
[1]N. Rajasekaran, et al. CHS-114: A Cytolytic Anti-CCR8 Antibody that Depletes Tumor-infiltrating Regulatory T Cells as a Treatment for Head and Neck Squamous Cell Carcinoma. Volume 118, Issue 5e89April 01, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal Protein Kinase D2 Antibody [Alexa Fluor 700]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-99858AF700 0.1 mL
Rabbit Polyclonal Protein Kinase D2 Antibody [Alexa Fluor 700]
Ask
View Details G3038-50 10 mg
N- (b-D-Glucopyranosyl) -N'-[ (2-methanethiosulfonyl) ethyl] Urea (MTS-5-Glucose)
Ask
View Details